Welcome to Central Library, SUST

Food and drug regulation in an era of globalized markets / (Record no. 85040)

MARC details
000 -LEADER
fixed length control field 06086cam a22005411i 4500
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230830103147.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu|||unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150902t20152015ne ob 001 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780128025505
Qualifying information (electronic bk.)
International Standard Book Number 0128025506
Qualifying information (electronic bk.)
International Standard Book Number 0128023112
International Standard Book Number 9780128023112
Canceled/invalid ISBN 9780128023112
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)919611878
Canceled/invalid control number (OCoLC)968043852
-- (OCoLC)969044783
-- (OCoLC)1058408889
-- (OCoLC)1088961524
-- (OCoLC)1097098724
-- (OCoLC)1155994937
-- (OCoLC)1162283423
-- (OCoLC)1164897561
-- (OCoLC)1166212274
-- (OCoLC)1168702867
-- (OCoLC)1172298081
-- (OCoLC)1203853789
-- (OCoLC)1204876443
-- (OCoLC)1221572141
-- (OCoLC)1224710539
-- (OCoLC)1227629396
-- (OCoLC)1228601762
040 ## - CATALOGING SOURCE
Original cataloging agency N$T
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency N$T
Modifying agency N$T
-- YDXCP
-- IDEBK
-- OPELS
-- CDX
-- EBLCP
-- OCLCF
-- D6H
-- OCLCQ
-- U3W
-- CUY
-- ZCU
-- MERUC
-- AU@
-- FEM
-- LOA
-- ICG
-- MERER
-- K6U
-- COCUF
-- OCLCQ
-- VT2
-- DKC
-- OCLCQ
-- ESU
-- UK7LJ
-- HS0
-- UWK
-- NLE
-- SXB
-- UHL
-- LDP
-- EUN
-- OCLCQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number K3636.F66
072 #7 - SUBJECT CATEGORY CODE
Subject category code LAW
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 344.0423
Edition number 23
245 00 - TITLE STATEMENT
Title Food and drug regulation in an era of globalized markets /
Statement of responsibility, etc. edited by Sam F. Halabi.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Amsterdam ;
-- Boston :
Name of producer, publisher, distributor, manufacturer Academic Press, an imprint of Elsevier,
Date of production, publication, distribution, manufacture, or copyright notice [2015]
Date of production, publication, distribution, manufacture, or copyright notice ©2015
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Front Cover; Food and Drug Regulation in an Era of Globalized Markets; Copyright; Contents; Contributors; Foreword; Introduction; The Rise of a Global System for Food and Pharmaceuticals; Conceptualizing Food and Drug Regulation in Globalized Markets: Interdisciplinarity and Governance; The Plan of This Book; Acknowledgments; Acknowledgments; Part I: Governance, Regulation, and Vulnerabilities of Globalized Pharmaceutical Supply Chains ; Chapter 1: Addressing Emerging Challenges in the Pharmaceutical Product Development Ecosystem; Introduction.
Formatted contents note Approaches to Reduce Drug Development Costs and Speed InnovationClinical Trials: Reducing Costs, Speeding Development: New Approaches to Patient Recruitment, Study Design, and Settings; Adaptive Design; Clinical Trials: Globalization; New Approaches to Endpoints: Biomarkers, Patient Reporting, and Remote Monitoring; The Supply Chain: How Are We Vulnerable and What Are Potential Solutions?; Big (More and More) Data: Swim or Drown?; Conclusion; Chapter 2: FDA's Global Investigation and Enforcement Authority, Partnerships, and Priorities; Introduction; Adulteration, Misbranding, and GMPs.
Formatted contents note FDA Establishment InspectionsFDA Enforcement Instruments Related to Manufacturing; Foreign Inspections; Conclusion; Chapter 3: The European Medicines Agency and the Regulation of Medicines in the European Union; Introduction; Approval of Drugs in Europe; The European Medicines Agency: Its Role and Activities; Ema Support In The Early Stages Of Drug Development; The Centralized Procedure AT WORK; Assessment overview; Single Assessment Report; Patients in the Scientific Review Process; Transparency and the Centralized Procedure; EMA-FDA Cooperation; Cooperation in the Product Life Cycle.
Formatted contents note Cooperation in InspectionsBenefits of International Cooperation; References; Chapter 4: Human Clinical Trials and Drug Approvals: Transnational Issues; Introduction; Taking Clinical Trials Abroad; Overlapping Legal and Regulatory Requirements; Legal Landscape in the United States: FDA Oversight of Clinical Trials; Legal Landscape in the EU: EU Clinical Trial Directives and Regulation; International Legal Landscape: International Clinical Practice Standards; National and Local Legal Standards; Practical Considerations in Conducting Global Trials.
Formatted contents note Deciding Whether to Conduct the Foreign Clinical Trial Under an INDIdentifying Experienced Contractors and Contract Research Organizations; Managing Idiosyncratic Foreign Sites and Investigators; Conclusion; Further Reading; Chapter 5: Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains: Toward Actionable Solutions; Globalization's Influence on the Pharmaceutical Supply Chain; The Effects of the Global Market for Falsified and Substandard Medicines; Barriers to Global Solutions for the Problem of Falsified and Substandard Medicines.
520 ## - SUMMARY, ETC.
Summary, etc. Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing pharmaceutical sectors in China and India. From the changing nature of packaged and processed food supply chains, to the reorientation of pharmaceutical research and funding coalesced to confront firms, regulators, and consumers are now faced with previously unknown challenges. Based on the 2014 O'Neill Institute Summer program, this book provides an international, cross-disciplinary look at the changing world of regulations and offers insights into requirements for successful implementation.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Vendor-supplied metadata.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Law and legislation.
9 (RLIN) 63786
Topical term or geographic name as entry element Pharmacy
General subdivision Law and legislation.
9 (RLIN) 63787
Topical term or geographic name as entry element Food law and legislation.
9 (RLIN) 63788
Topical term or geographic name as entry element LAW
General subdivision Administrative Law & Regulatory Practice.
Source of heading or term bisacsh
9 (RLIN) 63789
Topical term or geographic name as entry element Drugs
General subdivision Law and legislation.
Source of heading or term fast
Authority record control number (OCoLC)fst00898830
9 (RLIN) 63790
Topical term or geographic name as entry element Food law and legislation.
Source of heading or term fast
Authority record control number (OCoLC)fst00930954
9 (RLIN) 63791
Topical term or geographic name as entry element Pharmacy
General subdivision Law and legislation.
Source of heading or term fast
Authority record control number (OCoLC)fst01060303
9 (RLIN) 63792
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Halabi, Sam F.,
Relator term editor.
9 (RLIN) 63793
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Food and drug regulation in an era of globalized markets.
Place, publisher, and date of publication London, England : Academic Press, ©2015
Physical description xli, 215 pages
International Standard Book Number 9780128023112
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified ELSEVIER
Uniform Resource Identifier <a href="https://www.sciencedirect.com/science/book/9780128023112">https://www.sciencedirect.com/science/book/9780128023112</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type eBooks

No items available.